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Summary     
INTRODUCTION
 Human enterovirus (HEVs) infection is common, with an extensive array of clinical 
displays  ranging from asymptomatic to life-threatening. Presentation include nonspecific febrile 
illness often accompanied by muscle pain, sore throat, abdominal discomfort, rash, headache, 
encephalitis, aseptic meningitis and acute flaccid paralysis [2]. 
 
OBJECTIVES
 The study objective was to investigate the natural selection and genetic variability of HEVs 
and to identify HEV serotypes in circulation among children below 5 years old with diarrhea in 
an informal settlement(Kibera) in Kenya.
METHODOLOGY
 Specimens (n=628) from a prospective cohort study assessing the incidence and etiology of 
diarrhea from 2009-2015 were analyzed. Enteric Taqman array cards (TAC) were used for initial 
screening where two hundred and nine (78%) tested positive for HEVs. 
	 Of	these	specimens,	72	(42%)	had	a	cycle	threshold	(Ct)	≤30	and	were	tested	by	conventional	
PCR	targeting	the	3’	regions	of	 the	viral	protein	1	(VP1)	gene.	A	total	of	48	(67%)	underwent	
sequencing;	 11	 (23%)	 of	 which	 yielded	 nucleotide sequences. Phylogenetic analyses clustered 
the Kenyan serotypes to HEVs groups C, B and A. Evaluation of the VP1 amino acid sequences 
revealed numerous amino acid substitutions in relation to reference strains, which were confirmed 
to be due to natural selection by negative or positive selection.
CONCLUSION
 The Heterogeneous nature of stool samples is known to influence disparities in viral 
nucleic acid yields. TAC detected 209 of which 171 (82%) were confirmed positive for HEVs by 
real-time	 reverse	 transcription	 polymerase	 chain	 reaction	 (RRT-PCR),	 targeting	 the	 5’	 NTR	
regions. Therefore, the results may not be a representative of all circulating HEVs in the study 
area.  Since this was a retrospective study of previously collected samples, it is possible that some 
HEVs strains may have failed to amplify. 
[Afr. J. Health Sci. 2019 ; 32(2) : 15 - 33]
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Introduction  
 Human enteroviruses (HEVs) belong to the 
Picornaviridae family and are associated with a wide 
spectrum of clinical disease ranging from asymptomatic 
to severe life threatening [1]. 
 
 Clinical presentations include nonspecific 
febrile illness often accompanied by muscle pain, 
sore throat, abdominal discomfort, rash, headache, 
encephalitis, aseptic meningitis and acute flaccid 
paralysis [2]. 
 Most infections are mild or asymptomatic, 
although some infections may progress to severe 
diseases. Particularly in immuno - compromised 
individuals and children under five years this is 
possible[3, 4, 5 ].
 
 The Picornaviruses are small in size (22 to 
30 nm) non-enveloped, single-stranded, positive-sense 
RNA viruses with a genome of about 7,500 nucleotides 
and an icosahedral symmetry [6]. 
 The virus capsid consists of four polypeptides 
viral proteins (VP1-4). HEVs serotypes are defined 
by neutralizing epitopes of the virus capsid proteins, 
predominantly VP1 as well as VP2 and VP3 [7]. 
 The VP1 protein is the outermost viral capsid 
protein and contains key neutralization sites thus an 
ideal target for vaccine development [2, 7]. 
 Besides being a major neutralization site, several 
other determinants are mapped to the VP1 including 
determinants of virulence, virion thermostability, host 
range alteration and obstinate infection [8]. 
 The VP1 partial genome sequence is sufficient 




 for serotype determination [2, 9, 10]. 
 More than 100 serotypes of non - polio 
enteroviruses are currently recognized worldwide with 
additional antigenic variants within serotypes defined 
by reduced nonreciprocal cross - neutralization between 
prototype and variant strains [7]. 
 HEVs have a high rate of mutation and 
recombination because they co - circulate in human 
and animal hosts, rapidly evolving to create new 
variants [9, 10]. 
 Natural selection due to both negative and 
positive pressures has been known to shape patterns 
of nucleotide polymorphism as observed herein where 
nucleotide substitutions were confirmed to be as a 
result of negative and positive selection [7]. 
 Whereas negative or purifying selection deletes 
mutations that are disadvantageous to the virus, positive 
selection increases the frequency of advantageous 
mutations. These two forces contribute to the fitness of 
the virus within its environment increasing its chances 
of survival and dominance [7, 9, 10].
 Following the infection, HEVs are transmitted 
via respiratory droplets, feces, and in some cases via 
conjunctival secretions and skin lesion exudates [8, 9].
 
 Detection of HEVs from the gastrointestinal 
tract provides evidence of infection, although viral 
shedding at these sites may also happen in the absence 
of symptoms [5]. 
 Stool specimens of infected HEVs individuals 
have higher viral titers with persistent viral shedding for 
several weeks following the onset of infection [6, 11]. 
 
 This study was to determine the serotypes of 
HEVs circulating in Kibera. 
 During the study period; establishment of 
phylogenetic relationships of HEVs, determination of 
the genetic evolution and natural selection of the Kenyan 
HEVs was important.
 We report on the molecular characteristics of 
HEVs	types	detected	in	stool	samples	from	children	≤5	
years with diarrhea in Kibera, Kenya between 2009 and 




 The stool samples were collected through the 
Population-Based Infectious Disease Surveillance 
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(PBIDS) platform, carried out by the Kenya Medical 
Research Institute (KEMRI) and the US Centers for 
Disease Control and Prevention (CDC) in Kibera.
 Kibera is a large urban informal settlement 
located 7 kilometers Southwest of Nairobi's Central 
Business. It is characterized by congested population 
with deprived hygiene standards [12]. 
 PBIDS participants received free medical care 
for acute illness at a centrally located clinic. Stool 
samples Which were collected from those with diarrhea, 
were	equal	or	grater	than	three	(	≥	3)	stools	in	24-hours	
or clinician diagnosis of diarrhea). 
 A subset of archived specimen collected from 
children aged <5 years from 2009 to 2015 were tested 
using enteric TAC in 2016.
Criteria for selection for TAC testing included: 
(a) Children less than two (<2) years with diarrhea
(b) Children less than(<5) years with two or more  
 diarrhea illness for which a stool was provided
(C) Children less than(<5) years with diarrhea 
(d) Children from a household with Human  
 Immunodeficiency Virus-infected member. 
 Of 831 specimens from children meeting those 
criteria,	631	(76%)	were	available	for	TAC	testing	[1-3].
 
Extraction of Nucleic Acid Material
 From stool samples, 180 – 220 mg or 200ul of 
liquid were extracted using a modified QIAamp Fast 
Stool Mini Kit procedure where they underwent a 
lysate preparation process that included a mechanical 
disruption step (bead beating), removal of inhibitors, 
purification and elution of nucleic material using spin 
columns. 
 The lysate was transferred into the spin columns 
and centrifuged at 15,600Xg for 1 minute. The columns 
were washed twice according to the manufacturer’s 
instructions by adding 500µl wash solution, centrifuging 
at 15,600Xg for 1 minute and eluted with 100µl total 
nucleic acid (TNA) [13].
RT-PCR
 The nucleic material was analyzed using an 
entero-pathogen TAC card pre-coated with multiple 
sets of primers and probe concordant to the conserved 
5′-untranslated	 region	 of	 the	 enterovirus	 genome	 [14,	
15]. 
 A master mix was prepared using the Ag-Path-
ID One-Step RT-PCR Kit (Life Technologies, Foster 
City, CA) as follows; 
(a) 50 µL of the buffer, 
(b) 4 µL enzyme mix 
(c) 26µL nuclease-free water per reaction. 
 A total volume of 100 µL: 80 µL of master mix 
and 20 µL of TNA were loaded per reaction. 
 All TAC tests were run on the Applied 
Biosystems ViiA7 Real-Time PCR system (Life 
Technologies). Thermo cycling conditions of 10 min at 
45°C for reverse transcription; 10 min at 94°C activation 
of Taq polymerase. 
 Subsequent 45 cycles consisting of cDNA 
denaturation step for 15s at 95°C and a combined 
annealing-extension step of 1 min at 60°C were 
employed.
 Samples with a Cycle threshold (Ct) value of 
≤35	were	confirmed	by	RRT-PCR	[15].	
 Briefly, 25µl reaction mixtures were made 
containing: 
a. 12.5µL of 2x Taq man one-step RRT-PCR  
 master mix buffer, 
b. 1µl 40x Multi Scribe and RNase inhibitor  
 mixture, 
c. 1µM forward primer, 
d. 1µM reverse primer, 
e. 1µM probe (Table 7), 
18 African Journal of Health Sciences, Volume 32, Issue No. 2, March - April 2019
 A standardized in-house protocol was used for 





moles/µL forward and reverse primers (292 and 222 
in Table 8);	1	μL	of	SuperScript	 III	RT/Platinum	Taq	
mix	and	4	μL	of	the	RNA	template	was	used	for	each	
reaction. 
 The reaction mix were incubated at 50°C for 45 
min; 94°C for 3min then thermo cycling was performed 
for 40 cycles of 94°C for 30s; 42°C for 1 min and 60°C 
for 2 min followed by a final extension at 60°C for 10 
min.in a model 9700 thermocycler (Applied Biosystems, 
Foster City, CA) [2]. 
 The reaction products were analyzed by 
electrophoresis	 in	 a	 1%	agarose	 gel	 and	 staining	with	
0.5 mg/ml ethidium bromide.
Primer or probe Sequence Nucleotide position 
Forward primer 5’-TCCTCCGGCCCCTGA 452-466
Reverse primer 1 5’-AATTGTCACCATAAGCAGCCA 607-587
Reverse primer 2 5’-GATTGTCACCATAAGCAGCCA 607-587
Probe 1 5’-CGGAACCGACTACTTTGGGTGTCCGT 541-566
Probe 2 5’-CGGAACCGACTACTTTGGGTGACCGT 541-566
f. 5.75µl nuclease-free water 
g. 5µL of purified RNA (or nuclease-free water  
 for controls). 
 The reaction was incubated at 50°C for 30 
min followed by 94°C for 3 min. Thermo cycling was 
cDNA Synthesis and Amplification
performed for 45 cycles at 94°C for 30 s, 42°C for 30 
s and 72°C for 30 s in a 7500F model thermocycler 
(Applied	Biosystems).	Ct	values	of	≤30	were	considered	
for sequencing. 
Table 7: Primers used for RT-PCR 
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 Natural selection signatures were detected 
from the DNA sequences using SLAC/FEL/BUSTED 
methods implemented in the Data monkey [17, 18]. 
 Natural selective pressure on VP1 was surveyed 
by appraising the ratio of non-synonymous (dN) to 
synonymous	(dS)	substitutions	(ω = dN/dS)	on	a	codon	
by codon basis through the lineages. 
 To determine whether any particular codon 
location on VP1 was under positive selection, both the 
FEL and SLAC methods were applied [17].
 For those that failed on SLAC and FEL analyses, 
BUSTED analysis was applied to determine evidence of 




TAC and RT-PCR Results
 Of the 628 stool specimens tested by the 
enteric Taqman array cards (TAC) assay on the ViiA 
7	 instrument	 (Life	 Technologies),	 209	 (33%)	 tested	
positive	for	HEV	with	a	cut-off	Cycle	threshold	(Ct)	of	≤	
30 recommended for the enteric TAC (12). 
	 Of	 these,	 171	 (82%)	 were	 confirmed	 positive	
for HEVs by a subsequent real-time RT-PCR assay, 
targeting the 5’ NTR region performed on the ABI 
7500	F	instrument	(Ct	≤40).	Specimens	with	a	Ct	≤30	
by	RRT-PCR	(n=72;	42%),	were	tested	by	conventional	
PCR targeting the 3’ region of the VP1 gene. 
	 Of	 these,	 48	 (67%)	 specimens	 gave	 a	 band	 of	
approximately 350bp, and their nucleotide sequences 
were determined. 
Table 8: Primers Used For Amplification and Sequencing 





HEV292 MIGCIGYIGARACNGG VP1 2612–2627 All EV
HEV222 CICCIGGIGGIAYRWACAT VP1 2969–2951 All EV
Nucleotide Sequencing
 Gel bands of approximately 350bp were excised 
and purified using the Promega gel purification kit 
(Wizard® SV Gel and PCR Clean-Up System, Madison, 
Wisconsin). Sequencing of the purified PCR amplicons 
was performed using the BigDye Terminator version 3.1 
Cycle Sequencing kit (Applied Bio systems, Foster City, 
CA).
 The product was further purified using 
sephadex-50 (Sigma Aldrich Co; USA). PCR products 
were finally loaded in an automated 3500 Genetic 
Analyzer (Applied Bio systems Foster City, CA).
 
Sequence Assembly and 
Data Analysis
 The sequences were aligned using the ClustalW 
algorithm implemented in MEGA6. The Bayesian 
phylogenetic trees were based on partial VP1 nucleotide 
gene sequences of HEV. Phylogenetic analysis was 
performed using MrBayes 3.2 [16] employing the 
general time-reversible (GTR + Gamma) substitution 
model estimated in MEGA 6. A posterior probability 
was shown in percentages on each node. 
 The identity of each specimen was determined 
to be the serotype of the highest scoring strain in Gen 
Bank using the Basic Local Alignment Search Tool 
(BLAST) followed by the pair-wise comparison of the 
partial VP1 sequences to VP1 sequences of prototypes 
and variant strains from Gen Bank 
 Homologous strains from various African 
countries were selected according to proximity to study 
strains upon applying the BLAST tool. Nucleotide 
sequences	 displaying	 a	 percent	 identity	 of	 ≥75%	 or	
≥85%	amino	acid	homology	and	above	were	considered	
sufficient for serotype assignment [2]. 
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Figure 1: Sample Testing Algorithm For Human Enterovirus Stool From Children Below Five Years In Kibera Kenya
Sequencing Results
Nucleotide and Amino Acid Homology 
Results
	 Eleven	 (23%)	 of	 the	 sequenced	 samples	
yielded usable nucleotide sequences amongst which, 
two sequences	 ≥200nt	 were	 deposited	 in	 Gen	 Bank	
with accession numbers MG838739 and MG838740 
(Table1).  
628 stool samples available for TAC 
Testing
 209 (33%) positive for Enterovirus 
by TAC   underwent rRT-PCR Testing
72 (34%) positive for Enterovirus 
by RRT-PCR (with a Ct ≤30) 
underwent conventional PCR
48 (67%) samples with expected 
band length (350bp) underwent 
sequencing
419 (67%) negative for 
Enterovirus by TAC
24(33%) unexpected band 
length or smear
38 (18%) negative for 
Enterovirus by RRT-PCR
11 (23%) readable sequences analyzed
99 (47%) Ct>30 by RRT-PCR
37 (77%) no readable sequence
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KEN_KIBERA_03 Enterovirus A76 2009 A MG838740
KEN_KIBERA_10 Echovirus E12 2009 B -
KEN_KIBERA_16 Echovirus E13 2010 B -
KEN_KIBERA_15  Echovirus E25 2011 B -
KEN_KIBERA_17 Echovirus E9 2012 B -
KEN_KIBERA_01 Coxsackie A24 2013 C -
KEN_KIBERA_04 Coxsackie A13 2013 C -
KEN_KIBERA_06 Coxsackie A13 2013 C -
KEN_KIBERA_13 Coxsackie A13 2014 C -
KEN_KIBERA_05 Coxsackie A20 2014 C MG838739
KEN_KIBERA_11 Enterovirus C99 2015 C -
 These two belong to HEV-A76 and CV-A20 
serotypes. Phylogenic analyses of the 11 nucleotide 
sequences, revealed a total of 9 HEV serotypes. 
Interestingly, an Echovirus E13 from year 2010 clustered 
together with group C instead of group B (Fig 2). 
	 The	 HEV-A76	 strain	 had	 an	 88%	 nucleotide	






and	85%	 to	91%	amino	acid	 identity	 to	other	African	
homologous strains (Table 2). 
Table 1: All Human Enterovirus Serotypes and Clade/Species Identified In Stool Specimens From Kibera. Kenya  
 2009 - 2015. Nine different serotypes were identified showing HEV serotype diversity within this population.
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HEV - A76 Nucleotide % Identity














Table 2: Nucleotide and Amino Acid Homology Of Kenyan HEV-A76 and Cv-A20 In Relation To   
 Prototypes and Homologous African Strains.
Phylogeny Results
 Phylogenetic analysis of the VP1 region of the 
Kenyan HEV serotypes with HEV prototypes strains 
retrieved from Gen Bank revealed that these viruses 
separated into three main clusters: A, B and C (Fig. 2). 
Most of the Kenyan strains belonged to group C (6/11, 
55%)	and	group	B	(4/11,	36%)	while	one	(9%)	belonged	
to group A. The HEV serotypes showed diversity when 
compared to homologous strains from Kenya and other 
African countries (Fig. 3).
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Figure 3: Bayesian Phylogenetic Tree Of The VP1 Region Showing Kenyan Serotypes In Relation To Homologous  
    Strains From Other African Countries.
Amino acid Substitution Amongst the Kenyan HEVs 
 The HEV-A76 strain in this study showed 
an amino-acid substitution (Q103M) in VP1 when 
compared to prototype strain, HEV76_FRA91 (Fig 4; 
Table 3). 
 The CV-A20 had nine- amino-acid substitutions 
compared to the prototype strain, CVA20_IH35. The 
amino acid substitutions included: A58G; R83C; A85G; 
C86W; Y95N; I101T; E103T; T108A and T115S (Fig 
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 Amino acid substitutions at codon 108 had 
a consensus in all homologous strains selected for 
comparison (Fig 5; Table 3). CV-A13 study serotypes 
had 22 inter-serotype amino acid substitutions observed 
among the study CV-A13 and a deletion at codon site154 
(Fig 6)
Figure 4:   Vp1 Amino Acid Sequence Alignment Of The Kenyan HEV-A76 Strain Relative To The Prototype FRA91  
      Strain and Other Homologous African Strains. 
concurred with Niger and Cameroon strains and varied 
with some homologous strains from the two countries. 
Amino acid substitutions at codon E103T differed in 
the homologous strains under comparison; Niger and 
Cameroon strains had E103K while Cameroon strains 
had I103Q. 
       60 70 80 90 100
     . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I
AY697458_HEV76_FRA91       ETGATSNTTDENMIETRAVINKHSTEETCIEHFFSRAGLVSMISLLVSEE
KEN_KIBERA_03	 	 	 ..................................................................................................................
JX307650.1		 Human	enterovirus	7	 ...................................................................................................................
KY433796.1	 Enterovirus	A76	iso	 .............................................................................................................
EU481516.1 Human enterovirus 7 ----------.................................................................................................
EU481517.1 Human enterovirus 7 --..............................................................................................................
EU481518.1 Human enterovirus 7 ---------------N............................................................................................
JX307650.1	 Human	enterovirus	7	 ...................................................................................................................
KY433796.1	 Entrovirus	A76				iso	 ................................................................................................................
	 	 	 	 		 	 110	 120	 130	 140	 150
     . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I . . . . I
AY697458_HEV76_FRA91       TTQAYANWEIDTMGFVQMRRKLEMFTYMRFNAEFTFVATGLNGTAPQTML
KEN_KIBERA_03	 	 	 ..M.............................................................................................................
JX307650.1		 Human	enterovirus	7	 ................................................................................................X-----------	
KY433796.1	 Enterovirus	A76	iso	 .....................................................................................................PP.....
EU481516.1 Human enterovirus 7 ..............................................................................................................
EU481517.1 Human enterovirus 7 ................................................................................................................
EU481518.1 Human enterovirus 7 ....................................................................................................................
JX307650.1	 Human	enterovirus	7	 ...................................................................................................................
KY433796.1	 Entrovirus	A76				iso	 ..................................................................................................X----------	
26 African Journal of Health Sciences, Volume 32, Issue No. 2, March - April 2019
HEV Codon Changes
Serotype Codon Positions                  From To
Codon      Amino acid Codon       Amino acid
HEV - A76 103 CAG         Glutamine       ATG         Methionine
58 GCT         Alanine GGT         Glycine
83 CGG        Arginine TGT        Cysteine
85 GCG        Alanine GGG        Glycine
86 TGT         Cysteine TGG       Tryptophan
CV - A20 95 TAC         Tyrosine AAC        Asparagine
101 ATC         Isoleucine ACT        Threonine
103 GAG        Glutamic acid ACA        Threonine
108 ACC         Threonine GCA        Alanine
115 ACA         Threonine AGC        Serine
Table 3:  Nucleotide Substitutions That Translated In Amino Acid Changes In Kenyan HEV-A76 and CV-A20. 
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Figure 5 : VP1 Amino Acid Sequence Alignment Of The Kenyan CV-A20 Strain Relative To The   
     Prototype IH35 Strain And Other Homologous African Strains.
Figure 6: Inter-serotype amino acid sequence alignment of the Kenyan CV-A13 serotypes h.
    h Amino acid inter-serotype substitutions in study strain CV-A13. A deletion was also observed at codon  
    sites 154 compared to the prototype Flores strain.
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Evolutionary Pressure amongst 
the Kenyan HEVs
 Both FEL and SLAC analyses indicated a 
significant	 (p	 =	 0.05)	 negative	 selection/pressure	




0.024) by SLAC analyses (Table 4). 
 FEL analysis also determined significant 
positive and negative selection in study strain CV - A20 
(p	 =	 0.05).	 	 Positive	 selection	was	 observed	 at	 codon	
171	(p	=	0.046)	and	negative	selection	at	codon	181	(p	=	
0.039) (Table 5). 
 SLAC and FEL analyses did not find any positive 
or negative selection site to the other study strains which 
could be attributed to their short sequences. 
 However, Branch-Site Unrestricted Statistical 
Test for Episodic Diversification (BUSTED) found 
significant evidence (Likelihood Ratio Test (LRT, 
p-value	 =	 ≤	 0.05)	 of	 positive	 selection	 in	 the	 selected	
test branches of ECHO-E25 and other study serotypes 
(Table 6) . 
Analysis Codon Site Alpha(Ds) Beta (Dn) Alpha = Beta P-Value
FEL 78 22.23 0.00 1.79 0.03
FEL 88 8.37 0.00 2.34 0.03
FEL 111 23.04 0.00 7.38 0.03
SLAC 111 3.47 0.00 -5.58 0.02
FEL 112 20.99 0.00 1.75 0.03
FEL 116 17.23 0.00 1.76 0.05
e (dN) non-synonymous; (dS) synonymous substitutions
Table 4: Negative selection of HEV-A76 serotype by FEL and SLAC analysis.  Significant negative selection was   
	 observed	at	p	values	≤0.05	by	both	analyses	e
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Table 5: Negative and Positive Selection Sites In Kenyan CV - A20 by FEL analysis f
Codon Site  (dS) (dN) dS = dN p-value Selection
171 0.00 296.54 34.48 0.05 Pos. Selection
181 10000 0.00 10.79 0.04 Neg. Selection
f Significant pervasive (p= 0.046) 
and purifying (p=0.039) selection in CV-A20 serotype at codon 171 and 181 respectively. 
(dN) non-synonymous; 
(dS) synonymous substitutions
Table 6:  ECHO-E25 BUSTED analysis.  Significant gene-wide episodic positive selection observed at codon sites 49  
   and 68 in ECHO-E25 Kenyan strain; p-value 0.01 and 0.03 respectively











49 -3.90 -3.82 -3.90 -0.16 0.01
68 -5.20 -5.12 -5.22 -0.16 0.03
Discussion
 Partial sequencing of the HEVs VP1 gene 
revealed that, strains belonging to groups A, B and 
C were in co-circulation in Kibera, Kenya during the 
study period (2009 - 2015). 
The HEVs serotypes reported in this study include: 
 a. CV - A24,   A13   and   A20 
 b. Echovirus E12,   E13,   E25,  and   E9 
 c. HEVs  A76  and   C99. 
 Previous studies of HEVs serotypes in stool 
and respiratory samples from Kenyan children had 
some overlap with our findings [20, 21].
 However, this study was the first to report 
HEVs A76; E13; E9, CV A13 and CV A20 amongst 
Kenyan children. 
 CV-A20 has been associated with aseptic 
meningitis, herpangina, myocarditis and Bornholm 
diseases [6]. 
 HEV - A76 is a recently reported HEVs serotype 
classified genetically as group A EV (EV-A) and is 
associated with viral encephalitis [22]. 
 Although HEV-76 is not among the most 
commonly reported HEVs serotypes [3]. It has caused 
various enterovirus outbreaks including the viral 
encephalitis outbreak that occurred in northern India in 
2006 [22]. 
 Nucleotide and amino acid homology results 
confirmed the HEV serotypes through amino acid 
identity to prototypes and variant strains [2]. 
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 Evolution and genomic diversity of the various 
HEVs circulating strains are important in identifying 
recombination and mutations that may contribute to the 
pathogenesis [11]. 
 Serotype multiplicity presents an environment 
for intra-serotype recombination that would determine 
the molecular characteristics of the virus population.
 Additionally, multi-serotype infections as well 
as the variations in viral antigenicity are responsible for 
epidemics [23]. 
 In the present study, ECHO-E13 clustered with 
group C HEVs despite being a group B HEVs suggesting 
that ECHO-E13 had genetic substitutions from group C 
species.
 The VP1 gene harbors the BC and DE - loops 
which are important immune-provoking regions 
connected with HEVs infectivity [20]. 
 Amino acid substitutions within these loops can 
considerably modify the host’s neutralizing response to 
the virus. 
 An example is the Echovirus 9 where cytolytic 
proficiencies of lytic clone-derived Echovirus 9 in 
human pancreatic islets have been reported to be altered 
by a single amino acid substitution (T81A) in the VP1 
capsid protein [24]. 
 We found that the ECHO-E9 strain identified 
in this study had the T81A amino acid substitution 
suggesting it could result in necrosis of the human 
pancreatic islets. 
 Amino acid substitutions have in some cases 
resulted in changes in viral antigenicity. For example, 
an amino acid alteration from alanine to threonine at 
position 107 in VP1 protein dramatically diminishes 
replication of EV-71 virus due to impaired maturation 
[25]. 
 A sole amino acid alteration at codon position 
103 observed in HEV-A76 translated to a variation from 
glutamine to methionine.
 Although further, in vitro studies could 
elucidate the impact of this amino acid substitution 
to host. Negative selection plays an imperative role 
in maintaining an enduring stability of a virus by 
eliminating lethal mutations [26]. 
 The numerous amino acid substitutions in study 
serotypes were confirmed as negative selection by FEL 
and SLAC analysis, suggesting purifying selection. 
These findings correlated well with previous findings 
by Opanda et al., 2016 that also suggested negative 
selection of circulating enteroviruses in the same age 
group in Kenya [7]. 
	 Strong	(p≤0.05)	negative	selection	as	observed	
in the HEVs serotype suggests elimination of highly 
deleterious variants whose genes have vital roles in the 
host and withstand limited amino acid substitutions to 
maintain stability [26].
 Evidence of negative and positive selection was 
observed in CV-A20 suggesting that both purifying and 
pervasive pressures are at play in this serotype strain.
 
 Positive selection in CV-A20 and ECHO-E25 
suggested a tendency of the virus to deviate from 
stabilizing selection by positively mutating residues in 
the antigenic epitope. 
 Particularly, those located on BC and DE 
loops thus promote subsequent divergence from other 
homologous HEVs serotypes. Positive selection on the 
VP1 region has been reported to mostly occur within 
the BC and DE regions [17]. 
 Consequently, positive selection identified 
in CV-A20 and other strains in this study could have 
antigenic effects. 
Conclusion
 This study had several limitations. First, the 
heterogeneous nature of stool samples is known to 
influence disparities in viral nucleic acids yields and 
could have contributed to the few samples analyzed in 
this study [27]. 
 TAC PCR primers were designed to capture a 
broad range of enteroviruses. Thus TAC detected 209 
specimens however only 171 could be confirmed with 
specific HEV RRT-PCR test [28]. 
 Sequencing was limited to specimen with 
RRT-PCR	Ct	values	≤30	and	not	all	sequenced	samples	
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yielded nucleotide sequences. The results therefore, 
may not be representative of all circulating HEVs in the 
study area.  
 Since this was a retrospective study of previously 
collected samples, it is possible that some HEVs strains 
may have failed to amplify; thus specimens from the 
earlier years of the study period may have been under 
represented. 
 The sole use of the VP1 gene to analyze the 
viruses was limiting; more analysis could have been 
done if we had performed whole genome sequencing 
(WGS) of the virus. 
 Notwithstanding these shortcomings, we 
established some of the HEVs serotypes in circulation 
in Kibera and their genetic diversity. We also found 
serotypes belonging to Enterovirus A, B, and C not 
previous reported in Kenya [7, 29]. 
 Findings from this study have also indicated 
pervasive and purifying pressure in some enterovirus 
serotypes which have been shown to contribute to 
patterns of nucleotide polymorphism in HEV [30]. 
 Inter-serotype differences of VP1 gene as 
observed among the study CV-A13 serotypes could be 
as a result of insertions or deletions of distinct amino 
acids that result in alterations of the virus capsid 
structure associated with divergent strains [18, 31].
 Future WGS studies will provide more insight 
into the genetic and evolutionary characteristics of 




 The study protocol was submitted and approved 
by the KEMRI's Scientific and Ethics Review Unit 
(SERU) under protocol number 3381. 
 Stool samples were collected under the protocol 
“Active population-based surveillance of SERU, major 
infectious disease syndromes in Western Kenya and 
Nairobi” (PBIDS). 
 This was approved by KEMRI under protocol 
numbers 932, 1899 and CDC Institutional Review Board 
Number 4566.
 Samples collected from the field were 
given unique Identification(IDs) with no patient's 
identification.
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